trilostane has been researched along with Cushing Syndrome in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (42.42) | 18.7374 |
| 1990's | 4 (12.12) | 18.2507 |
| 2000's | 6 (18.18) | 29.6817 |
| 2010's | 3 (9.09) | 24.3611 |
| 2020's | 6 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Aniballi, C; Barbarossa, A; de Marco, V; Fracassi, F; Galac, S; Golinelli, S; Leal, RO; Maietti, E; Tardo, AM | 1 |
| da Silva Mello, FP; da Silva, CC; de Carvalho, GLC; de Faria Valle, S; de Moura Martins, FS; Furtado, PV; Machado, L; Meirelles, L; Neto, WS; Pöppl, ÁG | 1 |
| Melián, C; Mendoza, P; Pérez-López, L | 1 |
| Aoshima, K; Nagata, N; Nakamura, K; Takiguchi, M | 1 |
| Lee, D; Lee, GW; Park, HM; Yoo, CR | 1 |
| Chai, SH; Kim, WH; Kweon, OK; Lee, A; Lee, S | 1 |
| Fels, L; Hoffrogge, S; Mischke, R; Schmicke, M | 1 |
| Boretti, F; Hofmann-Lehmann, R; Quante, S; Rentsch, K; Reusch, C; Riond, B; Salesov, E; Sieber-Ruckstuhl, N | 1 |
| McLean, CL | 1 |
| Baden, MY; Hosokawa, Y; Matsuzawa, Y; Obata, Y; Saisho, K; Tamba, S; Yamada, Y; Yamamoto, K | 1 |
| Hurley, KJ; Mooney, CT; Neiger, R; O'Connor, J; Ramsey, I | 1 |
| McGowan, CM; Neiger, R | 1 |
| Frost, R; McGowan, CM; Neiger, R; Pfeiffer, DU | 1 |
| Fenske, M; Hassan, J; Künzel, F; Zeugswetter, F | 1 |
| Mattingly, D; Tyler, C | 1 |
| Belchetz, PE; Davis, JC; Diver, MJ; Hipkin, LJ | 1 |
| Banks, R; Carter, G; MacGregor, G; Ward, PD | 1 |
| Bergstrand, CG; Nilsson, KO | 1 |
| Beastall, GH; Gray, CE; Semple, CG; Thomson, JA | 1 |
| Demura, H; Imaki, T; Miyagawa, M; Nomura, K; Ono, M; Shizume, K; Yano, T | 1 |
| Ando, A; Hashiba, T; Mikeo, T; Saito, Z; Takeda, J | 1 |
| Anderson, DC; Bu'lock, DE; Dewis, P; Earnshaw, R; Kelly, WF | 1 |
| Bricaire, H; Luton, JP | 1 |
| Engelhardt, D | 1 |
| Engelhardt, D; Weber, MM | 1 |
| Nishikawa, T; Saito, J | 1 |
| Füessl, HS | 1 |
| Komanicky, P; Melby, JC; Spark, RF | 1 |
| Katayama, T; Koike, H; Nakada, T | 1 |
| Adams, EF; Ashby, MJ; Burrin, J; Drucker, R; Mashiter, K; Stringer, K; Yeo, TH | 1 |
| Ishikawa, S; Katayama, T; Kazama, T; Koike, H; Nakada, T | 1 |
4 review(s) available for trilostane and Cushing Syndrome
| Article | Year |
|---|---|
Treatment of Cushing's disease in children.
Topics: Adrenalectomy; Adrenocorticotropic Hormone; Aminoglutethimide; Bromocriptine; Child; Cushing Syndrome; Cyproheptadine; Dihydrotestosterone; Female; Humans; Metyrapone; Mitotane; Pituitary Gland; Valproic Acid | 1982 |
Steroid biosynthesis inhibitors in Cushing's syndrome.
Topics: Adrenal Cortex Hormones; Aminoglutethimide; Cushing Syndrome; Dihydrotestosterone; Etomidate; Humans; Ketoconazole; Metyrapone; Mitotane | 1994 |
Therapy of Cushing's syndrome with steroid biosynthesis inhibitors.
Topics: 3-Hydroxysteroid Dehydrogenases; Aminoglutethimide; Cushing Syndrome; Dihydrotestosterone; Etomidate; Humans; Ketoconazole; Metyrapone; Steroids | 1994 |
[Clinical usefulness of pharmacological treatment of Cushing's syndrome].
Topics: Administration, Oral; Aminoglutethimide; Cushing Syndrome; Dihydrotestosterone; Humans; Ketoconazole; Metyrapone; Mitotane | 1994 |
2 trial(s) available for trilostane and Cushing Syndrome
| Article | Year |
|---|---|
Assessment of selegiline and trilostane combined therapy efficacy for canine pituitary-dependent hypercortisolism treatment: A pilot randomized clinical trial.
Topics: Adrenocorticotropic Hormone; Animals; Cushing Syndrome; Dihydrotestosterone; Dog Diseases; Dogs; Hydrocortisone; Pilot Projects; Pituitary ACTH Hypersecretion; Selegiline | 2022 |
Effects of Trilostane on urinary Catecholamines and their metabolites in dogs with Hypercortisolism.
Topics: Animals; Catecholamines; Cushing Syndrome; Dihydrotestosterone; Dog Diseases; Dogs; Epinephrine; Female; Male; Metanephrine; Norepinephrine; Normetanephrine; Prospective Studies | 2017 |
27 other study(ies) available for trilostane and Cushing Syndrome
| Article | Year |
|---|---|
Comparison of methods to monitor dogs with hypercortisolism treated with trilostane.
Topics: Adrenocortical Hyperfunction; Animals; Cross-Sectional Studies; Cushing Syndrome; Dihydrotestosterone; Dog Diseases; Dogs; Enzyme Inhibitors; Hydrocortisone; Prospective Studies | 2021 |
Effects of concurrent canine Cushing's syndrome and diabetes Mellitus on insulin requirements, trilostane dose, and survival time.
Topics: Animals; Cushing Syndrome; Diabetes Mellitus; Dog Diseases; Dogs; Hydrocortisone; Insulin; Retrospective Studies | 2023 |
Adrenocortical hypoperfusion detected by contrast-enhanced ultrasound in a dog with trilostane-induced hypoadrenocorticism.
Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Animals; Cushing Syndrome; Dog Diseases; Dogs; Hydrocortisone; Male; Necrosis | 2023 |
Favorable outcome of pheochromocytoma in a dog with atypical Cushing's syndrome and diabetes mellitus following medical treatment: a case report.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Animals; Antineoplastic Agents; Cushing Syndrome; Diabetes Mellitus; Dihydrotestosterone; Dog Diseases; Dogs; Hypoglycemic Agents; Insulin; Male; Phenoxybenzamine; Pheochromocytoma; Treatment Outcome | 2020 |
Ectopic Cushing's syndrome associated with a pheochromocytoma in a dog: a case report.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Animals; Cushing Syndrome; Dihydrotestosterone; Dog Diseases; Dogs; Male; Phenoxybenzamine; Pheochromocytoma | 2020 |
[Atypical Cushing's syndrome in a dog. A case report].
Topics: Adrenocorticotropic Hormone; Animals; Cushing Syndrome; Dihydrotestosterone; Dog Diseases; Dogs; Male | 2017 |
Management of Cushing's syndrome in dogs.
Topics: Adrenocorticotropic Hormone; Androgens; Animals; Cushing Syndrome; Dihydrotestosterone; Dog Diseases; Dogs; Research; Surveys and Questionnaires | 2009 |
Long-term efficacy of trilostane for Cushing's syndrome due to adrenocorticotropin-independent bilateral macronodular adrenocortical hyperplasia.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Cushing Syndrome; Dihydrotestosterone; Humans; Hyperplasia; Male; Middle Aged; Time Factors; Treatment Outcome | 2011 |
Trilostane treatment of 78 dogs with pituitary-dependent hyperadrenocorticism.
Topics: Abortifacient Agents, Steroidal; Adrenocorticotropic Hormone; Animals; Cushing Syndrome; Dihydrotestosterone; Dog Diseases; Dogs; Female; Male | 2002 |
Efficacy of trilostane for the treatment of equine Cushing's syndrome.
Topics: 3-Hydroxysteroid Dehydrogenases; Adrenocorticotropic Hormone; Animals; Cushing Syndrome; Dihydrotestosterone; Enzyme Inhibitors; Female; Horse Diseases; Horses; Hydrocortisone; Male; Safety; Treatment Outcome | 2003 |
Serum insulin concentrations in horses with equine Cushing's syndrome: response to a cortisol inhibitor and prognostic value.
Topics: 3-Hydroxysteroid Dehydrogenases; Animals; Biomarkers; Cushing Syndrome; Dihydrotestosterone; Enzyme Inhibitors; Horse Diseases; Horses; Hydrocortisone; Insulin; Predictive Value of Tests; Prognosis; Sensitivity and Specificity; Survival Analysis | 2004 |
Cushing's syndrome in a guinea pig.
Topics: Adrenal Glands; Alopecia; Animals; Cushing Syndrome; Dihydrotestosterone; Female; Guinea Pigs; Rodent Diseases; Treatment Outcome; Ultrasonography | 2007 |
Trilostane interference with fluorimetric steroid assays.
Topics: 11-Hydroxycorticosteroids; Androstanols; Cushing Syndrome; Dihydrotestosterone; Drug Interactions; Female; Fluorometry; Humans; Nitriles; Spectrometry, Fluorescence | 1981 |
Problems with trilostane.
Topics: Androstanols; Cushing Syndrome; Depression, Chemical; Dihydrotestosterone; Humans; Male; Middle Aged; Nitriles; Testis; Testosterone | 1981 |
Trilostane as cause of Addisonian crisis.
Topics: Addison Disease; Cushing Syndrome; Dihydrotestosterone; Humans; Male; Middle Aged | 1981 |
Trilostane in the management of Cushing's syndrome.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Cushing Syndrome; Dihydrotestosterone; Drug Evaluation; Female; Humans; Hydrocortisone; Male; Middle Aged | 1983 |
Concomitant falls of plasma cortisol and ACTH levels in a case of Cushing's disease during treatment with trilostane.
Topics: 17-Hydroxycorticosteroids; Adrenocorticotropic Hormone; Aged; Cushing Syndrome; Dihydrotestosterone; Female; Humans; Hydrocortisone; Lypressin; Metyrapone | 1984 |
[Trilostane therapy in patients with hypercorticism].
Topics: 3-Hydroxysteroid Dehydrogenases; Adult; Cushing Syndrome; Dihydrotestosterone; Female; Humans; Hydrocortisone; Hyperaldosteronism; Male; Middle Aged; Oxidative Phosphorylation Coupling Factors | 1984 |
Experience with trilostane in the treatment of Cushing's syndrome.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Cushing Syndrome; Dihydrotestosterone; Dose-Response Relationship, Drug; Female; Humans; Hydrocortisone; Male; Middle Aged | 1983 |
Trilostane (Modrenal).
Topics: Cushing Syndrome; Dihydrotestosterone; Humans; Hyperaldosteronism | 1982 |
[Cushing's syndrome. Medical treatment of adrenal hypercorticism].
Topics: Adrenal Gland Neoplasms; Aminoglutethimide; Androstanols; Bromocriptine; Cushing Syndrome; Cyproheptadine; Dihydrotestosterone; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Metyrapone; Mitotane; Nitriles | 1980 |
[Secondary forms of hypertension. 5. Hypertension caused by Cushing syndrome and Conn's disease].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocorticotropic Hormone; Algorithms; Cushing Syndrome; Diagnosis, Differential; Dihydrotestosterone; Diuretics; Enzyme Inhibitors; Humans; Hyperaldosteronism; Hypertension; Magnetic Resonance Angiography; Mineralocorticoid Receptor Antagonists; Pituitary Neoplasms; Spironolactone; Tomography, X-Ray Computed | 2002 |
Treatment of Cushing's syndrome with trilostane (WIN 24,540), an inhibitor of adrenal steroid biosynthesis.
Topics: 17-Ketosteroids; Adrenal Cortex Hormones; Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Adult; Blood Pressure; Carcinoma; Cushing Syndrome; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Female; Humans; Hydrocortisone; Kinetics; Male; Middle Aged; Mineralocorticoids; Potassium; Renin | 1978 |
Uneventful delivery following series of successive treatments for virilized Cushing syndrome due to adrenocortical carcinoma.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adult; Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Cushing Syndrome; Dihydrotestosterone; Female; Humans; Pregnancy | 1990 |
Effect of nivazol on ACTH secretion by human pituitary corticotrophic tumours in cell culture.
Topics: Adrenocorticotropic Hormone; Arginine Vasopressin; Cells, Cultured; Corticotropin-Releasing Hormone; Cushing Syndrome; Dihydrotestosterone; Humans; Pituitary Neoplasms; Pregnadienes | 1985 |
[Effect of a 3 beta-hydroxysteroid dehydrogenase inhibitor (trilostane) on Cushing's syndrome].
Topics: 3-Hydroxysteroid Dehydrogenases; Adult; Cushing Syndrome; Dihydrotestosterone; Female; Humans | 1985 |
Trilostane for Cushing's syndrome.
Topics: Adult; Cushing Syndrome; Dihydrotestosterone; Humans; Hydrocortisone | 1985 |